期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 127, 期 1, 页码 7-10出版社
WILEY
DOI: 10.1002/jso.27104
关键词
cancer; COVID-19; multidisciplinary; surgical; treatment
The management strategies for surgical oncology patients need to be reconsidered due to the impact of the COVID-19 pandemic on their survival and tumor progression rates.
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据